Alternative Methods in Science: Towards Fluidic Systems

Main Article Content

Francesca Caloni , Alessandra Cazzaniga, Arno C. Gutleb, Helena Kandarova, Giulia Ranaldi, Hassan Rashidi, Sonja von Aulock, Doris Wilflingseder
[show affiliations]

Article Details

How to Cite
Caloni, F., Cazzaniga, A., Gutleb, A. C., Kandarova, H., Ranaldi, G., Rashidi, H., von Aulock, S. and Wilflingseder, D. (2023) “Alternative Methods in Science: Towards Fluidic Systems”, ALTEX - Alternatives to animal experimentation, 40(4), pp. 694–696. doi: 10.14573/altex.2307101.
Meeting Reports

Chary, A., Groff, K., Stuck, A. O. et al. (2022). Maximizing the relevance and reproducibility of A549 cell culture using FBS-free media. Toxicol In Vitro 83, 105423. doi:10.1016/j.tiv.2022.105423

Dalsbecker, P., Beck Adiels, C. and Goksör, M. (2022). Liver-on-a-chip devices: The pros and cons of complexity. Am J Physiol Gastrointest Liver Physiol 323, G188-G204. doi:10.1152/ajpgi.00346.2021

Gough, A., Soto-Gutierrez, A., Vernetti, L. et al. (2021). Human biomimetic liver microphysiology systems in drug development and precision medicine. Nat Rev Gastroenterol Hepatol 18, 252-268. doi:10.1038/s41575-020-00386-1

Lauschke, V. M., Vorrink, S. U., Moro, S. M. L. et al. (2016). Massive rearrangements of cellular MicroRNA signatures are key drivers of hepatocyte dedifferentiation. Hepatology 64, 1743-1756. doi:10.1002/hep.28780

Lauschke, V. M., Milani, L. and Ingelman-Sundberg, M. (2017). Pharmacogenomic biomarkers for improved drug therapy-recent progress and future developments. AAPS J 20, 4. doi:10.1208/s12248-017-0161-x

O’Brien, P. J., Irwin, W., Diaz, D. et al. (2006). High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch Toxicol 80, 580-604. doi:10.1007/s00204-006-0091-3

Sirenko, O., Hesley, J., Rusyn, I. et al. (2014). High-content assays for hepatotoxicity using induced pluripotent stem cell-derived cells. Assay Drug Dev Technol 12, 43-54. doi:10.1089/adt.2013.520

Tolosa, L., Pinto, S., Donato, M. T. et al. (2012). Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs. Toxicol Sci 127, 187-198. doi:10.1093/toxsci/kfs083

von Aulock, S., Busquet, F., Locke, P. et al. (2022). Engagement of scientists with the public and policymakers to promote alternative methods. ALTEX 39, 543-559. doi:10.14573/altex.2209261

Waring, M. J., Arrowsmith, J., Leach, A. R. et al. (2015). An analysis of the attrition of drug candidates from four major pharmaceutical companies. Nat Rev Drug Discov 14, 475-486. doi:10.1038/nrd4609

Zhao, P., Wang, J., Chen, C. et al. (2022). Microfluidic applications in drug development: Fabrication of drug carriers and drug toxicity screening. Micromachines 13, 200. doi:10.3390/mi13020200